FGFR2 and breast carcinoma: In addition, Czaplinska et al. found that fibroblast growth factor receptor 2 (FGFR2) can form an indirect complex with RSK2, which may be involved in the progression of breast cancer and lead to poor prognosis in breast cancer patients (Czaplinska et al., 2016).